
CPHI: Trends shaping pharma's path
Despite challenges such as funding slowdowns for biotechs and concerns about high inflation, the industry remains cautiously optimistic,...

Roche acquires Telavant Holdings to win TLA1 race
The takeover of Telavant, a 75:25 jont-venture of Roivant Sciences and the US pharmaceutical group Pfizer, however, may cost Roche up to US-$7.25bn....

Germany boosts protein transition with €38m
Germany is set to follow countries such as the Denmark, the UK and the Netherlands, which this year provided massive funding to become world...

AI protein specialist Cradle raises US$24m in Series A financing
Kindred Capital. and angel investors including Recursion CEO Chris Gibson and Tom Glocer, Lead Director, Merck participated it the US24m Series A...

Repairing MS-caused damage with stem cells
Results of a investigator-initiated Phase I stem cell therapy trial have shown promise as a treatment for progressive multiple sclerosis. The...

Scotland boosts bio-based manufacturing with £75m fund
Scottish Enterprise and Innovate UK will deliver the Launchpad programme, designed to focus on Scotland’s strengths in the sector. The packages,...

Orakl Oncology SA raises €3m to advance tumour modelling
French precision oncology start-up Orakl Oncology has raised €3m in a seed financing round led by Speedinvest with additional investment from...